Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/7/25 21:35 | 3/5/25 | NTRA | Health | Health | Medical Laboratories | Moshkevich Solomon | TX | O | P,CLINIC | 5 | S | -6,501 | 162.04 | 0 | -40 | 150 | D | |||||||||||||||
3/7/25 21:35 | 3/5/25 | NTRA | Health | Health | Medical Laboratories | Chapman Steven Leonard | TX | DO | CEO,P | 3 | S.d | -27,744 | 154.55 | 0 | -180 | 268 | D | |||||||||||||||
2/28/25 21:05 | 2/26/25 | NTRA | Health | Health | Medical Laboratories | Sheena Jonathan | TX | DH | CO-FOUND | 5 | S.dm | -3,141 | 162.86 | 0 | -19 | 396 | M | |||||||||||||||
2/7/25 21:35 | 2/6/25 | NTRA | Health | Health | Medical Laboratories | Fesko John | TX | O | P,CHIEF | 4 | S | -4,395 | 165.29 | 0 | -27 | 156 | D | |||||||||||||||
2/4/25 21:45 | 1/31/25 | NTRA | Health | Health | Medical Laboratories | Brophy Michael Burkes | TX | O | CFO | 5 | S.dm | -13,575 | 171.97 | 0 | -79 | 110 | D | |||||||||||||||
1/31/25 21:35 | 1/29/25 | NTRA | Health | Health | Medical Laboratories | Rabinowitz Matthew | TX | DO | Exec CB | 2 | S | -27,514 | 165.75 | 0 | -166 | 2,473 | D | |||||||||||||||
1/31/25 21:35 | 1/29/25 | NTRA | Health | Health | Medical Laboratories | Rabinowitz Daniel | TX | O | SEC.,GC | 3 | S.d | -5,518 | 167.04 | 0 | -33 | 218 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |